- Home
- XFOR vs PKBK Comparison
XFOR vs PKBK Comparison
Compare XFOR & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | PKBK |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | 143 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.5M | 353.1M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | XFOR | PKBK |
|---|---|---|
| Price | $4.35 | $30.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 304.0K | 81.1K |
| Earning Date | 05-04-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | N/A | ★ 39.21 |
| EPS | N/A | ★ 0.99 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $31.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $18.78 |
| 52 Week High | $4.83 | $32.09 |
Technical Indicators
Market Signals| Indicator | XFOR | PKBK |
|---|---|---|
| Relative Strength Index (RSI) | 57.03 | 53.09 |
| Support Level | $3.44 | $29.83 |
| Resistance Level | $4.57 | $31.35 |
| Average True Range (ATR) | 0.24 | 0.62 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 72.12 | 37.61 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending, among others. The company operates one reportable segment of business, community banking.